The paper says nothing about the critical role strong empathy plays when dealing with these children and adolescents. Whether this empathy is genuine or just evidence-based is something they are particularly sensitive about. The algorithm is too complex to be useful, especially in a statutory health insurance setting. It is unfortunate that fluoxetine is the only approved medicine. Of all selective serotonin reuptake inhibitors (SSRIs), it has the longest half-life and is thus the most difficult to control. As it contains only the active enantiomer, escitalopram can be recommended.
References
- 1.Dolle K, Schulte-Körne G. The treatment of depressive disorders in children and adolescents. Dtsch Arztebl Int. 2013;110(50):854–860. doi: 10.3238/arztebl.2013.0854. [DOI] [PMC free article] [PubMed] [Google Scholar]
